Incidence of Mortality and Complications After Lung Surgery, Open Thoracic Aortic Repair, TEVAR, EVAR.
Incidence of Perioperative Mortality and Major Complications in Patients Who Underwent Lung Surgery, Open Thoracic Aortic Repair, Thoracic Endovascular Aortic Repair (TEVAR), and Endovascular Aortic Repair (EVAR). A Retrospective Study
1 other identifier
observational
2,224
1 country
1
Brief Summary
Lung surgery, open aortic surgery, TEVAR, and EVAR are major operations that carry a higher incidence of perioperative mortality and complications compare to other surgery. The study of the incidence of mortality and complications will help the hospital to benchmark with the others. Also the study of the risk factors of mortality and major complications will help to improve the patients' outcomes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Oct 2021
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 2, 2021
CompletedFirst Posted
Study publicly available on registry
October 12, 2021
CompletedStudy Start
First participant enrolled
October 23, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2023
CompletedNovember 1, 2021
October 1, 2021
2.2 years
October 2, 2021
October 23, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Incidence of mortality and major complications after lung surgery
The mortality and major complications (CVS, CNS, RS and others) will be recorded.
30 days
Incidence of mortality and major complications after open aortic surgery
The mortality and major complications (CVS, CNS, RS and others) will be recorded.
30 days
Incidence of mortality and major complications after TEVAR
The mortality and major complications (CVS, CNS, RS and others) will be recorded.
30 days
Incidence of mortality and major complications after EVAR
The mortality and major complications (CVS, CNS, RS and others) will be recorded.
30 days
Secondary Outcomes (4)
Risk factors of mortality and major complications after lung surgery
30 days
Risk factors of mortality and major complications after open aortic surgery
30 days
Risk factors of mortality and major complications after TEVAR
30 days
Risk factors of mortality and major complications after EVAR
30 days
Other Outcomes (3)
Incidence of postoperative delirium
30 days
Incidence of low muscle mass
7 days
Risk factors of postoperative stroke.
30 days
Study Arms (4)
Lung surgery
Patients underwent lung surgery.
Open aortic suregry
Patients underwent open aortic surgery.
Thoracic endovascular aortic repair (TEVAR)
Patients underwent TEVAR.
Endovascular aneurysm repair (EVAR)
Patients underwent EVAR.
Interventions
Patients underwent lung surgery including wedge resection, lobectomy, segmentectomy, and pneumonectomy.
Patients underwent open thoracic surgery or thoracoabdominal aortic surgery.
Eligibility Criteria
Patients who underwent one of these types of surgery 1) thoracic surgery, 2) open thoracic aortic surgery, 3) TEVAR and 4) EVAR
You may qualify if:
- Patients underwent
- thoracic surgery
- open thoracic aortic surgery
- TEVAR
- EVAR
You may not qualify if:
- Emergency lung surgery
- Conversion from TEVAR to open thoracic surgery
- Conversion from EVAR to open aortic surgery
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Anesthesiology Department Siriraj Hospital
Bangkoknoi, Bangkok, 10700, Thailand
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sirilak Suksompong, MD
Mahidol University
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- FAMILY BASED
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 2, 2021
First Posted
October 12, 2021
Study Start
October 23, 2021
Primary Completion
December 31, 2023
Study Completion
December 31, 2023
Last Updated
November 1, 2021
Record last verified: 2021-10
Data Sharing
- IPD Sharing
- Will not share